126 related articles for article (PubMed ID: 37772580)
21. Variable Expression of S100 Protein in Sinonasal Malignant Mucosal Melanoma: A Potential Diagnostic Pitfall.
Xu X; Palsgrove D; Kurian E; Yan S; Oliai BR; Bishop JA
Head Neck Pathol; 2020 Dec; 14(4):929-935. PubMed ID: 32239440
[TBL] [Abstract][Full Text] [Related]
22. Lack of correlation between microvascular density and pathological features and outcomes in sinonasal and oral mucosal melanomas.
Kerr EH; Wang D; Lewis JS; Said-Al-Naief N; Hameed O
Head Neck Pathol; 2011 Sep; 5(3):199-204. PubMed ID: 21424261
[TBL] [Abstract][Full Text] [Related]
23. Treatment and prognosis in sinonasal mucosal melanoma: A retrospective analysis of 65 patients from a single cancer center.
Sun CZ; Li QL; Hu ZD; Jiang YE; Song M; Yang AK
Head Neck; 2014 May; 36(5):675-81. PubMed ID: 23606507
[TBL] [Abstract][Full Text] [Related]
24. Combined utility of p16 and BRAF V600E in the evaluation of spitzoid tumors: Superiority to PRAME and correlation with FISH.
McAfee JL; Scarborough R; Jia XS; Azzato EM; Astbury C; Ronen S; Andea AA; Billings SD; Ko JS
J Cutan Pathol; 2023 Feb; 50(2):155-168. PubMed ID: 36261329
[TBL] [Abstract][Full Text] [Related]
25. Cavernous sinus involvement is not a risk factor for the primary tumor site treatment outcome of Sinonasal adenoid cystic carcinoma.
Lee YC; Lee TJ; Tsang NM; Huang Y; Hsu CL; Hsin LJ; Lee YH; Chang KP
J Otolaryngol Head Neck Surg; 2018 Feb; 47(1):12. PubMed ID: 29402308
[TBL] [Abstract][Full Text] [Related]
26. Diagnostic utility of immunohistochemistry in concordance with mRNA analysis of PRAME in the stratification of high-risk uveal melanoma patients.
Kumar N; Singh MK; Singh L; Lomi N; Meel R; Pushker N; Sen S; Kashyap S
Hum Cell; 2023 Jan; 36(1):342-352. PubMed ID: 36282437
[TBL] [Abstract][Full Text] [Related]
27. PRAME Expression and Its Clinical Relevance in Hodgkin's Lymphoma.
Ercolak V; Paydas S; Bagir E; Ergin M; Seydaoglu G; Celik H; Yavu B; Tanriverdi K; Gunaldi M; Afsar CU; Duman BB
Acta Haematol; 2015; 134(4):199-207. PubMed ID: 26044287
[TBL] [Abstract][Full Text] [Related]
28. Cancer testis antigen (PRAME) as an independent marker for survival in oral squamous cell carcinoma (OSCC).
Haidari S; Tröltzsch M; Fliefel R; Jungbluth AA; Otto S; Fegg F; Liokatis P; Ahmadi N; Eberl M; Probst FA; Knösel T
J Oral Pathol Med; 2022 May; 51(5):421-428. PubMed ID: 35430758
[TBL] [Abstract][Full Text] [Related]
29. Relationship between clinical features, GEP class, and PRAME expression in uveal melanoma.
Schefler AC; Koca E; Bernicker EH; Correa ZM
Graefes Arch Clin Exp Ophthalmol; 2019 Jul; 257(7):1541-1545. PubMed ID: 31065847
[TBL] [Abstract][Full Text] [Related]
30. Immunotherapy in sinonasal melanoma: treatment patterns and outcomes compared to cutaneous melanoma.
Klebaner D; Saddawi-Konefka R; Finegersh A; Yan CH; Califano JA; London NR; Deconde AS; Faraji F
Int Forum Allergy Rhinol; 2020 Sep; 10(9):1087-1095. PubMed ID: 32623838
[TBL] [Abstract][Full Text] [Related]
31. Aberrant expression of HMB45 and negative PRAME expression in halo nevi.
Ruby KN; Li Z; Yan S
J Cutan Pathol; 2021 Apr; 48(4):519-525. PubMed ID: 33184871
[TBL] [Abstract][Full Text] [Related]
32. Patterns of Treatment Failure in Patients with Sinonasal Mucosal Melanoma.
Amit M; Tam S; Abdelmeguid AS; Kupferman ME; Su SY; Raza SM; DeMonte F; Hanna EY
Ann Surg Oncol; 2018 Jun; 25(6):1723-1729. PubMed ID: 29626308
[TBL] [Abstract][Full Text] [Related]
33. Prognostic significance of PRAME expression based on immunohistochemistry for diffuse large B-cell lymphoma patients treated with R-CHOP therapy.
Mitsuhashi K; Masuda A; Wang YH; Shiseki M; Motoji T
Int J Hematol; 2014 Jul; 100(1):88-95. PubMed ID: 24820636
[TBL] [Abstract][Full Text] [Related]
34. Nasal and paranasal sinus mucosal melanoma: Long-term survival outcomes and prognostic factors.
Abt NB; Miller LE; Mokhtari TE; Lin DT; Richmon JD; Deschler DG; Varvares MA; Puram SV
Am J Otolaryngol; 2021; 42(6):103070. PubMed ID: 33930681
[TBL] [Abstract][Full Text] [Related]
35. Primary Sinonasal Malignant Melanoma: Effect of Clinical and Histopathologic Prognostic Factors on Survival.
Göde S; Turhal G; Tarhan C; Yaman B; Kandiloğlu G; Öztürk K; Kaya İ; Midilli R; Karcı B
Balkan Med J; 2017 May; 34(3):255-262. PubMed ID: 28443572
[TBL] [Abstract][Full Text] [Related]
36. Preferentially Expressed Antigen in Melanoma Immunohistochemistry Labeling in Uveal Melanomas.
Ahmadian SS; Dryden IJ; Naranjo A; Toland A; Cayrol RA; Born DE; Egbert PS; Brown RA; Mruthyunjaya P; Lin JH
Ocul Oncol Pathol; 2022 Jun; 8(2):133-140. PubMed ID: 35959159
[TBL] [Abstract][Full Text] [Related]
37. Primary mucosal melanoma of the head and neck. Comparison of clinical presentation and histopathologic features of oral and sinonasal melanoma.
McLean N; Tighiouart M; Muller S
Oral Oncol; 2008 Nov; 44(11):1039-46. PubMed ID: 18396446
[TBL] [Abstract][Full Text] [Related]
38. Predictors of survival in mucosal melanoma of the head and neck.
Jethanamest D; Vila PM; Sikora AG; Morris LG
Ann Surg Oncol; 2011 Oct; 18(10):2748-56. PubMed ID: 21476106
[TBL] [Abstract][Full Text] [Related]
39. PRAME immunohistochemistry of spitzoid neoplasms.
Koh SS; Lau SK; Scapa JV; Cassarino DS
J Cutan Pathol; 2022 Aug; 49(8):709-716. PubMed ID: 35488519
[TBL] [Abstract][Full Text] [Related]
40. Comparison of Immunohistochemistry for PRAME With Cytogenetic Test Results in the Evaluation of Challenging Melanocytic Tumors.
Lezcano C; Jungbluth AA; Busam KJ
Am J Surg Pathol; 2020 Jul; 44(7):893-900. PubMed ID: 32317605
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
